Statistical methods of indirect comparison with real-world data for survival endpoint under non-proportional hazards

被引:5
|
作者
Lin, Zihan [1 ]
Zhao, Dan [2 ]
Lin, Junjing [3 ]
Ni, Ai [1 ]
Lin, Jianchang [3 ]
机构
[1] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA
[2] Servier Pharmaceut, Biometr Dept, Boston, MA 02210 USA
[3] Takeda Pharmaceut, Stat & Quantitat Sci, Cambridge, MA 02139 USA
关键词
causal inference; non-proportional hazards; real-world data; survival analysis; propensity score; PROPENSITY-SCORE; RANK TEST; CAUSAL; SUBCLASSIFICATION; ESTIMATOR; OUTCOMES; ROBUST; BIAS;
D O I
10.1080/10543406.2022.2080696
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In clinical studies that utilize real-world data, time-to-event outcomes are often germane to scientific questions of interest. Two main obstacles are the presence of non-proportional hazards and confounding bias. Existing methods that could adjust for NPH or confounding bias, but no previous work delineated the complexity of simultaneous adjustments for both. In this paper, a propensity score stratified MaxCombo and weighted Cox model is proposed. This model can adjust for confounding bias and NPH and can be pre-specified when NPH pattern is unknown in advance. The method has robust performance as demonstrated in simulation studies and in a case study.
引用
收藏
页码:582 / 599
页数:18
相关论文
共 50 条
  • [41] Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data
    Bokemeyer, Carsten
    Paracha, Noman
    Lassen, Ulrik
    Italiano, Antoine
    Sullivan, Sean D.
    Marian, Marisca
    Brega, Nicoletta
    Garcia-Foncillas, Jesus
    [J]. JCO PRECISION ONCOLOGY, 2023, 7
  • [42] Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions.
    Horn, Leora
    Lin, Huamao Mark
    Padda, Sukhmani Kaur
    Aggarwal, Charu
    McCoach, Caroline Elizabeth
    Zhu, Yanyan
    Yin, Yu
    Lin, Jianchang
    Li, Shuanglian
    Feng, Zhongling
    Neal, Joel W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Association of COX-inhibitors with cancer patients' survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis
    Flausino, Lucas E.
    Ferreira, Isabella N.
    Tuan, Wen-Jan
    Estevez-Diz, Maria Del Pilar
    Chammas, Roger
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [44] A STATISTICAL COMPARISON OF LOGISTIC REGRESSION VERSUS MACHINE LEARNING TREE-BASED CLASSIFICATION METHODS IN PREDICTING CORONARY HEART DISEASE USING REAL-WORLD PATIENT-LEVEL DATA
    Smolen, H.
    [J]. VALUE IN HEALTH, 2019, 22 : S563 - S564
  • [45] Longitudinal Vehicle Dynamics: A Comparison of Physical and Data-Driven Models Under Large-Scale Real-World Driving Conditions
    James, Sebastian S.
    Anderson, Sean R.
    Da Lio, Mauro
    [J]. IEEE ACCESS, 2020, 8 : 73714 - 73729
  • [46] ESTIMATING LIFE EXPECTANCY BY EXTRAPOLATING RELATIVE SURVIVAL: COMPARISON OF THE FLEXIBLE PARAMETRIC MODEL AND THE ROLLING EXTRAPOLATION ALGORITHM USING REAL-WORLD CANCER DATA
    Chen, E. Y. T.
    Wang, J. D.
    Lin, C. N.
    Leontyeva, Y.
    Dickman, P. W.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S530 - S530
  • [47] Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival
    Liu, Zongzhi
    Lee, Kyeryoung
    Cohn, David
    Zhang, Mingwei
    Ai, Lei
    Li, Minghao
    Zhang, Xingming
    Jun, Tomi
    Higashi, Mitchell K.
    Pan, Qi
    Oh, William
    Stolovitzky, Gustavo
    Schadt, Eric
    Wang, Xiaoyan
    Li, Shuyu D.
    [J]. JOURNAL OF THORACIC DISEASE, 2023, 15 (05) : 2438 - +
  • [48] REAL-WORLD OVERALL SURVIVAL OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: RESULTS OF A CLAIMS DATA STUDY OF PATIENTS IN GERMANY
    Gottschalk, F.
    Cizova, D.
    Mueller, S.
    Myers, D.
    Wilke, T.
    Maywald, U.
    [J]. VALUE IN HEALTH, 2018, 21 : S24 - S24
  • [49] STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data
    Wang, Zhenxin
    Zhang, Guoqing
    Li, Zhongcheng
    Li, Jin
    Ma, Hongbo
    Hei, Ailian
    Jiao, Shunchang
    Hu, Yi
    Sun, Shengjie
    Wu, Liangliang
    Zhou, Ji
    Wang, Yu
    He, Ellen
    Skog, Sven
    [J]. FUTURE SCIENCE OA, 2021, 7 (03):
  • [50] INDIRECT COMPARISON OF DARATUMUMAB MONOTHERAPY VERSUS REAL-WORLD HISTORICAL CONTROL DATA IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE HEAVILY PRE-TREATED AND HIGHLY REFRACTORY
    Diels, J.
    Lam, A.
    Ito, T.
    Ng, Y.
    Mehra, M.
    Khan, I
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A140 - A140